These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6662343)

  • 1. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: II. Serotonin implicated.
    Kaada B; Eielsen O
    Gen Pharmacol; 1983; 14(6):635-41. PubMed ID: 6662343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: I. Failure to block the response by antagonists of endogenous vasodilators.
    Kaada B; Eielsen O
    Gen Pharmacol; 1983; 14(6):623-33. PubMed ID: 6319223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: III. Increase in plasma VIP in normal subjects and in Raynaud's disease.
    Kaada B; Olsen E; Eielsen O
    Gen Pharmacol; 1984; 15(2):107-13. PubMed ID: 6714637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: IV. In vitro bioassay of the vasoinhibitory activity of sera from patients suffering from peripheral ischaemia.
    Kaada B; Helle KB
    Gen Pharmacol; 1984; 15(2):115-22. PubMed ID: 6714638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy).
    Kaada B
    Eur Heart J; 1982 Aug; 3(4):303-14. PubMed ID: 6982164
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
    Khan F; Coffman JD
    Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.
    Lemaire I; Tseng R; Lemaire S
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6240-2. PubMed ID: 153530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular responses to histamine at low temperatures in normal digital skin and Raynaud's phenomenon.
    Bunker CB; Foreman JC; Dowd PM
    Agents Actions; 1991 May; 33(1-2):197-9. PubMed ID: 1716828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.
    Marasini B; Bassani C
    Br J Clin Pharmacol; 1990 Dec; 30(6):847-51. PubMed ID: 2288831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of brain serotonergic terminals in the antinociceptive action of peripherally applied calcitonin.
    Yamazaki N; Umeno H; Kuraishi Y
    Jpn J Pharmacol; 1999 Dec; 81(4):367-74. PubMed ID: 10669042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that serotonin receptors mediate the cutaneous vasoconstriction produced by 5-hydroxytryptamine in canine forelimbs.
    Dobbins DE; Adamski SW; Lokhandwala MF; Grega GJ
    Circ Res; 1983 Oct; 53(4):473-81. PubMed ID: 6627607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.
    Heier MS; Nilsen T; Graver V; Aass N; Fosså SD
    Br J Cancer; 1991 Apr; 63(4):550-2. PubMed ID: 1850610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human growth hormone secretion by melatonin and cyproheptadine.
    Smythe GA; Lazarus L
    J Clin Invest; 1974 Jul; 54(1):116-21. PubMed ID: 4600047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of the serotonergic system in intraseptal opioid-induced hypothermia in ground squirrels.
    Cui Y; Lee TF; Wang LC
    Ann N Y Acad Sci; 1997 Mar; 813():192-6. PubMed ID: 9100882
    [No Abstract]   [Full Text] [Related]  

  • 16. Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: pharmacological evidence.
    Wang RY; Aghajanian GK
    Neuropharmacology; 1978 Oct; 17(10):819-25. PubMed ID: 154620
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrical stimulation of the gastrocnemius muscle in the spontaneously hypertensive rat increases the pain threshold: role of different serotonergic receptors.
    Hoffmann P; Skarphedinsson JO; Delle M; Thorén P
    Acta Physiol Scand; 1990 Feb; 138(2):125-31. PubMed ID: 2138403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of serotonin, serotonin antagonists, some vasoactive substances and temperature on carrageenin-induced tail thrombosis in rats and mice.
    Bekemeier H; Hirschelmann R
    Agents Actions; 1986 Aug; 18(5-6):581-5. PubMed ID: 3766313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired skin microvascular reactivity in painful diabetic neuropathy.
    Quattrini C; Harris ND; Malik RA; Tesfaye S
    Diabetes Care; 2007 Mar; 30(3):655-9. PubMed ID: 17327336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and the vascular wall.
    Vanhoutte PM
    Int J Cardiol; 1987 Feb; 14(2):189-203. PubMed ID: 3818135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.